摘要:
A molecule able to modulate the expression of at least a gene involved in degradative pathways so to enhance the cellular degradative pathways and prevent or antagonize the accumulation of toxic compounds in a cell wherein said molecule acts on a CLEAR element; and/or on the TFEB protein activity or amount. The molecule may be used in the treatment of neurodegenerative and/or lysosomal storage disorders.
摘要:
The present invention relates to a mixture of molecules comprising at least one miRNA and at least one siRNA, or at least two miRNAs, or at least two siRNAs for inducing hematopoietic differentiation or for treating leukemia wherein the miRNA is able to modulate hematopoietic differentiation and/or to act as oncosuppressor, and the siRNA is able to modulate hematopoietic differentiation or to inhibit the expression of a fusion product deriving from a chromosomic translocation associated to leukemia.
摘要:
The present invention relates to a recording medium a method and an apparatus for generating virtual teeth. According to an embodiment of the present invention, a method for generating virtual teeth includes(a) acquiring a tooth image having three-dimensional information from teeth including a damaged tooth; (b) determining an image of a virtual tooth to be inserted into a position of the damaged tooth in a tooth image library having predetermined three-dimensional information and inserting the determined virtual tooth image into the acquired tooth image; and (c) modifying the virtual tooth image by considering tooth images positioned at upper and lower sides or right and left sides of the virtual tooth image. According to the embodiment of the present invention, it is possible to produce a prosthesis most suitable for the state of patient's teeth only once and an operator can minimize post-processing of the produced prosthesis. Further, a patient can minimize a clinic time and decrease the number of times of hospital visits.
摘要:
The present invention provides a pharmaceutical product and a process for bone regeneration and neoformation, which uses sirtuin modulators such as resveratrol and/or trans-resveratrol. Among the several advantages of the invention, worth of notice is the substantial acceleration in the process of integration of biomaterials to the body, substantially shortening the recovery period of the injured or lost organ.
摘要:
A gene is described that encodes for a snRNA modified such that it contains an antisense sequence complementary to at least one of the two splice junctions at 5' and/or 3' of one of the exons encoding for a protein of therapeutic interest, whose sequence should be skipped during the splicing process that converts the pre-mRNA to the mature mRNA. The gene is particularly advantageous which it contain segments complementary to both splice junctions. If introduced into appropriate vectors, the gene is useful in gene therapy, particularly in the treatment of Duchenne Muscular Dystrophies. dystrophic diseases.
摘要:
Provided is a reflection type optical sensor device including: a semiconductor light source (210) being formed by providing a light emitting region on a predetermined region of a substrate (230); and a photo-detection element (220) being integrated on the same substrate (230) as the substrate where the semiconductor light source (210) is formed to surround an outer circumferential surface of the semiconductor light source (210), and including a light receiving region. When the light emitted from the semiconductor light source (210) is reflected by an external object, the photo-detection element (220) may detect the light to sense the object. Through this, it is possible to reduce cost and ensure a small size. Also, the photo-detection element (220) is constructed to surround the outer circumferential surface of the semiconductor light source (210), and thus more accurately detect the light.
摘要:
The present invention provides a method for preparing standardized serum mixture for determining allergen potency which comprises: 1) providing multiple serum samples from patients moderately hypersensitive to said allergen; 2) determining the relative content of sIgE against said allergen in each serum sample, obtaining the mean value of the relative content of sIgE of said multiple serum samples, and obtaining deviation value of the relative content of sIgE of each serum with respect to said mean value; 3) removing at least 5% of serum samples that have the largest and smallest deviation values respectively, and mixing the residual sera at the same volume. The invention also relates to the serum mixture prepared by the method as well as the use of such serum mixture.